Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01012089 · ClinicalTrials.gov registry record · NA
Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01012089: Completed NA study, sponsored by University of Oklahoma.
NCT01012089 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01012089, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1. Study the pharmacokinetics and safety of daptomycin in children on hemodialysis (HD) and peritoneal dialysis (PD). 2. Determine urine, HD and PD clearance of daptomycin.
Interventions
- DRUG Daptomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01012089 record still lists
NCT01012089 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Daptomycin is the first listed.
NCT01012089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01012089 about?
NCT01012089 is a clinical study titled "Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease". The purpose of this study is to: 1. Study the pharmacokinetics and safety of daptomycin in children on hemodialysis (HD) and peritoneal dialysis (PD). 2. Determine urine, HD and PD clearance of daptomycin.
What is the current status of trial NCT01012089?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2009-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01012089?
The interventions under investigation include: Daptomycin (DRUG).
Who is sponsoring clinical trial NCT01012089?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01012089's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia